Drugs / 68Ga-GP-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07045428 | Oct 2025 → Jun 2026 overdue | — | GrandPharma (China) Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-GP-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07045428 ↗ |
| Route | Intravenous | “given through a vein (IV)” NCT07045428 ↗ |